Cargando…

Impact of Diabetes Status and Medication on Presentation, Treatment, and Outcome of Stage II Colon Cancer Patients

Diabetes is a risk factor for colorectal cancer and several reports suggest worse cancer-specific outcomes in diabetes patients. Recent studies in multiple tumour types indicate metformin may positively impact on cancer-specific and overall survival. A population-based series of stage II colorectal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bae, Susie, Wong, Hui-Li, Tie, Jeanne, Desai, Jayesh, Field, Kathryn, Kosmider, Suzanne, Fourlanos, Spiros, Jones, Ian, Skinner, Iain, Gibbs, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436511/ https://www.ncbi.nlm.nih.gov/pubmed/26074965 http://dx.doi.org/10.1155/2015/189132

Ejemplares similares

Health economic evidence for adjuvant chemotherapy in stage II and III colon cancer: a systematic review
por: To, Yat Hang, et al.
Publicado: (2023)

Cost-effectiveness analysis of imaging surveillance in stage II and III extremity soft tissue sarcoma: an Australian perspective
por: Bae, Susie, et al.
Publicado: (2020)

Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study
por: To, Yat Hang, et al.
Publicado: (2023)

CD8(+) tumor‐infiltrating lymphocytes within the primary tumor of patients with synchronous de novo metastatic colorectal carcinoma do not track with survival
por: Millen, Rosemary, et al.
Publicado: (2020)

Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer
por: Mendis, Shehara, et al.
Publicado: (2022)

Evidence That Nasal Insulin Induces Immune Tolerance to Insulin in Adults With Autoimmune Diabetes
por: Fourlanos, Spiros, et al.
Publicado: (2011)

A pilot study of the feasibility of empagliflozin in recent-onset type 1 diabetes
por: Wentworth, John M., et al.
Publicado: (2020)

A mutant BRAF V600E-specific immunohistochemical assay: correlation with molecular mutation status and clinical outcome in colorectal cancer
por: Day, Fiona, et al.
Publicado: (2014)

The Pro‐Diab Melbourne Perioperative Study: A structured pre‐admission perioperative diabetes management plan to improve medication usage in elective surgery
por: Qi, Qi Yang Damien, et al.
Publicado: (2022)

Patterns of care for patients with advanced soft tissue sarcoma: experience from Australian sarcoma services
por: Bae, Susie, et al.
Publicado: (2016)

Adjuvant Chemotherapy for Stage II Colon Cancer
por: Rebuzzi, Sara Elena, et al.
Publicado: (2020)

A Phase Ib/II Trial of Combined BRAF and EGFR Inhibition in BRAF V600E Positive Metastatic Colorectal Cancer and Other Cancers: The EVICT (Erlotinib and Vemurafenib In Combination Trial) Study
por: Tan, Lavinia, et al.
Publicado: (2023)

In-hospital hyperglycemia but not diabetes mellitus alone is associated with increased in-hospital mortality in community-acquired pneumonia (CAP): a systematic review and meta-analysis of observational studies prior to COVID-19
por: Barmanray, Rahul D, et al.
Publicado: (2022)

Contrast Increment and Decrement Processing in Individuals With and Without Diabetes
por: Tang, Vanessa Thien Sze, et al.
Publicado: (2023)

Circulating tumor DNA dynamics and recurrence risk in patients undergoing curative intent resection of colorectal cancer liver metastases: A prospective cohort study
por: Tie, Jeanne, et al.
Publicado: (2021)

De-escalating chemotherapy for stage II colon cancer?
por: Fu, Jianfei, et al.
Publicado: (2019)

ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
por: Naidoo, Mahendra, et al.
Publicado: (2021)

Re: Molecular testing to deliver personalised chemotherapy recommendations
por: Gibbs, Peter, et al.
Publicado: (2023)

How I treat stage II colon cancer patients
por: Taieb, J., et al.
Publicado: (2021)

Evaluation of lymph node numbers for adequate staging of Stage II and III colon cancer
por: Shanmugam, Chandrakumar, et al.
Publicado: (2011)

Immunoscore(®) as a predictor of response to chemotherapy in stage II and stage III colon cancer
por: Mlecnik, Bernhard, et al.
Publicado: (2015)

Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon Cancer
por: Viñal, David, et al.
Publicado: (2022)

Variations of Surveillance Practice for Patients with Bone Sarcoma: A Survey of Australian Sarcoma Clinicians
por: Lewin, Jeremy, et al.
Publicado: (2017)

Current colorectal cancer chemotherapy dosing limitations and novel assessments to personalize treatments
por: Arafat, Yasser, et al.
Publicado: (2022)

The Rising Incidence of Type 1 Diabetes Is Accounted for by Cases With Lower-Risk Human Leukocyte Antigen Genotypes
por: Fourlanos, Spiros, et al.
Publicado: (2008)

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma
por: Loft, Matthew, et al.
Publicado: (2019)

ATRT-08. A PHASE II STUDY OF CONTINUOUS LOW DOSE PANOBINOSTAT IN PAEDIATRIC PATIENTS WITH MALIGNANT RHABDOID TUMORS/ATYPICAL TERATOID RHABDOID TUMORS
por: Wood, Paul, et al.
Publicado: (2020)

ATRT-17. A phase II study of continuous low dose panobinostat in paediatric patients with malignant rhabdoid tumours and atypical teratoid rhabdoid tumours.
por: Wood, Paul, et al.
Publicado: (2022)

Prognostic Value of Stem Cell Quantification in Stage II Colon Cancer
por: Vaz, Maria Angeles, et al.
Publicado: (2014)

Risk Factors for Peritoneal Recurrence in Stage II to III Colon Cancer
por: Mayanagi, Shuhei, et al.
Publicado: (2018)

Adjuvant chemotherapy for stage II colon cancer: who really needs it
por: Yang, Yan, et al.
Publicado: (2018)

Challenges and solutions in patient treatment strategies for stage II colon cancer
por: Fotheringham, Susan, et al.
Publicado: (2019)

LAG-3 Expression Predicts Outcome in Stage II Colon Cancer
por: Rhyner Agocs, Gaëlle, et al.
Publicado: (2021)

Genomic profiling of stage II and III colon cancers reveals APC mutations to be associated with survival in stage III colon cancer patients
por: van den Broek, Evert, et al.
Publicado: (2016)

Left colon as a novel high-risk factor for postoperative recurrence of stage II colon cancer
por: Wang, Liming, et al.
Publicado: (2020)

The effect of smoking, obesity and diabetes on recurrence‐free and overall survival in patients with stage III colon cancer receiving adjuvant chemotherapy
por: Croese, Alex, et al.
Publicado: (2021)

CART-WHEEL.org: An Ethically Approved Online Database for Patient-Entered Data to Facilitate Rare Cancer Research
por: Kee, Damien, et al.
Publicado: (2020)

Combination of primary tumor location and mismatch repair status guides adjuvant chemotherapy in stage II colon cancer
por: Yang, Lin, et al.
Publicado: (2017)

Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status
por: Akce, Mehmet, et al.
Publicado: (2021)

SOX9 is associated with advanced T-stages of clinical stage II colon cancer in young Mexican patients
por: Lizárraga-Verdugo, Erik, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_st5bic59f30vvhull84cbe0lu4